Prescription savings
Stop paying too much for your prescriptions. Compare prices, get pharmacy coupons, and save up to 80%.Health conditions
Medications & treatment
Access & affordability
Resources
Sotyktu (deucravacitinib) is FDA approved to treat moderate-to-severe plaque psoriasis in adults. It's a type of Janus kinase (JAK) inhibitor called a tyrosine kinase 2 (TYK2) inhibitor. Sotyktu blocks the protein TYK2 in your body. This is thought to help lower inflammation that leads to psoriasis symptoms.